Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Orion to sell diagnostics division to Axcel
April 23, 2018

Orion Group sells its diagnostics division to Axcel, to focus solely on pharmaceuticals. The transaction is valued at 168M EUR and expected to be completed in Q2 2018. Orion states that the diagnostics division has no synergies with its core pharmaceutical business, which is the main rationale for the sale.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: